Bio Pharma Dive
NOVEMBER 13, 2020
An alliance with BeyondSpring spinout Seed Therapeutics makes Eli Lilly the latest pharma company to dive into the fast-emerging drug research field.
World of DTC Marketing
NOVEMBER 13, 2020
SUMMARY: Big pharma is still using outdated bureaucratic processes for everything from hiring to implementing marketing tactics to the point the industry is becoming more bloated. Unless employees challenge the status quo, DTC marketing will continue down a path to irrelevance. How long does it take to hire a new pharma employee? Would you believe the answer is between 4.5 and 6 weeks?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
NOVEMBER 13, 2020
With competition looming over one of its top drugs, Sumitomo Dainippon Pharma has been looking for new portfolio additions. It thinks it found one in Urovant Sciences.
pharmaphorum
NOVEMBER 13, 2020
Since Covid-19 hit, many industries have shifted a heavier weighting of their business into the online world, relying on e-commerce and digital engagement to counterbalance the reduced ability for physical interactions. The pharma world is no exception, and this year both small and large players have made the transition – partly out of necessity – from a world that relied predominantly on the face-to-face side of doing business, into a new digital world.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
XTalks
NOVEMBER 13, 2020
To help sufferers of nightmare disorder and nightmares associated with post-traumatic stress disorder (PTSD), the US Food and Drug Administration (FDA) has given marketing authorization for a wearable device that assists in reducing sleep disturbances associated with nightmares. Called Nightware, the device is a digital therapeutic that involves the use of an Apple Watch and an Apple iPhone which are connected to a software application and the Nightware server.
Druggist
NOVEMBER 13, 2020
Ibuprofen is a common medication used in the management of pain, fever, and to reduce inflammation. Alongside paracetamol (Calpol) it is one of the first medicines considered by parents when a child is ill. However, ibuprofen may not be recommended as the drug of choice in a particular group of children or to treat specific conditions. Today I answer the question: Can you use ibuprofen for chickenpox?
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
NOVEMBER 13, 2020
Credit: Christian Kroun Damgaard and Anne Kruse Hollensen. In a screening for a functional impact to the neuronal differentiation process, Danish researchers identified a specific circular RNA, circZNF827, which surprisingly “taps the brake” on neurogenesis. The results provide an interesting example of co-evolution of a circRNA, and its host-encoded protein product, that regulate each other’s […].
Pharma Times
NOVEMBER 13, 2020
Agreement follows positive phase III data announcement
Scienmag
NOVEMBER 13, 2020
University of Cincinnati fellow presents case related to COVID-19 during national meeting Credit: Colleen Kelley/University of Cincinnati A University of Cincinnati immunologist is recommending that individuals with contact dermatitis choose facial masks made without elastic or rubber that allow them to stay safe in the midst of COVID-19 while avoiding possible allergic reactions.
Pharma Times
NOVEMBER 13, 2020
Research centres will accelerate development of late-stage research within NHS
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
NOVEMBER 13, 2020
Smidt Heart Institute Chair of Cardiology presents new findings at American Heart Association Scientific Sessions Credit: Photo by Cedars-Sinai LOS ANGELES (Nov. 13, 2020) — New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty acids found in fish oil prevent the development of atrial fibrillation, […].
pharmaphorum
NOVEMBER 13, 2020
It’s day two of digital health innovation conference Frontiers Health, which will be mainly held online because of the COVID-19 pandemic. This year Frontiers will be a global Hybrid conference. In line with the “new normal” situation, the format of the 2020 edition will be hybrid combining online global streaming together with offline events and activities held at hubs in multiple locations such as Italy, Germany, Finland, Spain, the USA and more.
Scienmag
NOVEMBER 13, 2020
FDI World Dental Federation (FDI) releases new White Paper on antibiotic resistance to mark World Antimicrobial Awareness Week Credit: FDI World Dental Federation One of the unintended consequences of the COVID-19 lockdowns in England earlier this year has been a 25 per cent increase in the prescription of antibiotics by dentists, according to a new […].
pharmaphorum
NOVEMBER 13, 2020
Janssen has submitted a new combination regimen for its blockbuster multiple myeloma drug Darzalex for approval with the FDA and EMA, hoping to give the treatment another edge over emerging competitors. Specifically, the combination utilises the subcutaneous formulation of the drug, Darzalex Faspro (daratumumab/hyaluronidase) with Celgene’s multiple myeloma drug Imnovid (pomalidomide) and dexamethasone – which has gained new fame this year as one of the few treatments available for COVID-19.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
NOVEMBER 13, 2020
Environmental conservation expert discusses how new research will play a key role in promoting a greener future Credit: Photo courtesy of Christoph Nolte, Boston University. For decades, scientists have been warning about potential future effects of global climate change, including more frequent wildfires, longer periods of drought, and sharp increases in the number, duration, and […].
pharmaphorum
NOVEMBER 13, 2020
Janette Curlis is a Multiple Sclerosis Nurse Advisor (MSNA) at Biogen, helping to support the company’s Multiple Sclerosis (MS) field teams and developing patient and Healthcare Professional (HCP) materials. We spoke to her about being a bridge between pharma and the NHS and the challenges that are facing Multiple Sclerosis Nurses (MSNs) and patients today.
Scienmag
NOVEMBER 13, 2020
JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality A clinical study involving 601 patients in Italy and Spain suggests that the JAK inhibitor drug baricitinib may enhance survival rates of patients with severe COVID-19, primarily by blunting the runaway immune inflammation known as “cytokine storm.” While the authors […].
NY Times
NOVEMBER 13, 2020
A new study shows that more than half of enrollees don’t review or compare their coverage options annually.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
NOVEMBER 13, 2020
Findings from a national study published today in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19. The Outcomes Related to COVID-19 treated with Hydroxychloroquine among In-patients with symptomatic Disease (ORCHID) study found that, when compared to inactive placebo, hydroxychloroquine […].
Pharma Times
NOVEMBER 13, 2020
Treatment recommended for acquired thrombotic thrombocytopenic purpura
Scienmag
NOVEMBER 13, 2020
We are increasingly using more smart devices like smartphones, smart speakers, and wearable health and wellness sensors in our homes, offices, and public buildings. However, the batteries they use can deplete quickly and contain toxic and rare environmentally damaging chemicals, so researchers are looking for better ways to power the devices. One way to power […].
The Pharma Data
NOVEMBER 13, 2020
News. Professional. Many Certified Cosmetic Surgeons Not Trained in Surgical Discipline. FRIDAY, Nov. 13, 2020 — Many physicians advertising themselves as board-certified cosmetic surgeons are not as qualified as plastic surgeons, according to a study published in the November issue of Plastic and Reconstructive Surgery. Emily A. Long, from the Vanderbilt University School of Medicine in Nashville, Tennessee, and colleagues examined the training backgrounds and scope of practice of America
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
NOVEMBER 13, 2020
The BfR symposium discusses online how food can be made even safer and how consumers can be better protected For this reason, the German Federal Institute for Risk Assessment (BfR) is hosting an online symposium from 16 to 17 November 2020, which will focus on protection against listeria. “New methods, such as genetic analysis with […].
The Pharma Data
NOVEMBER 13, 2020
FRIDAY, Nov. 13, 2020 — Electronic cigarette use is associated with increased odds of cigarette smoking among adolescents with no previous smoking intention, according to a study published online Nov. 9 in Pediatrics. Olusegun Owotomo, M.D., Ph.D., from Children’s National Hospital in Washington, D.C., and colleagues analyzed data from 8,661 adolescent participants in waves 2 (2014 to 2015) and 3 (2015 to 2016) of the Population Assessment of Tobacco and Health Study to evaluate the
Scienmag
NOVEMBER 13, 2020
Study shows similar rates of ICU admission and severity of disease Credit: ACAAI ARLINGTON HEIGHTS, Ill (November 13, 2020) – During the COVID-19 pandemic, attention has been focused on how those with both allergies and asthma might be affected should they become ill. A new study being presented at this year’s virtual American College of […].
The Pharma Data
NOVEMBER 13, 2020
News. Professional. Outcomes Vary for Depression Collaborative Care Programs. FRIDAY, Nov. 13, 2020 — Real-world collaborative care programs for depression show large variation in clinical outcomes, according to a study published in the November issue of Health Affairs. Jürgen Unützer, M.D., M.P.H., from the University of Washington in Seattle, and colleagues used patient-reported outcome data from 11,303 patients receiving collaborative care for depression in 135 primary care clinics to e
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
NOVEMBER 13, 2020
Bottom Line: Deaths from cancer accounted for more than 4 million potential years of life lost in 2017. While the cancer types with the highest death rates per capita accounted for the greatest number of years lost, cancers that typically occur at younger ages bore a disproportionate share of the burden. Journal in Which the […].
The Pharma Data
NOVEMBER 13, 2020
FRIDAY, Nov. 13, 2020 — Breastfeeding is associated with fewer parent-reported behavioral difficulties, which decrease further with longer duration of breastfeeding, according to a study published online Nov. 9 in the Archives of Disease in Childhood. Lydia Gabriela Speyer, Ph.D., from the University of Edinburgh in the United Kingdom, and colleagues examined data from the Millennium Cohort Study involving 11,148 children, their parents, and teachers to examine the longitudinal effect of b
Scienmag
NOVEMBER 13, 2020
When it comes to “not sweating the small stuff,” mindfulness has its limitations, say UB researchers BUFFALO, N.Y. – If dispositional mindfulness can teach us anything about how we react to stress, it might be an unexpected lesson on its ineffectiveness at managing stress as it’s happening, according to new research from the University at […].
The Pharma Data
NOVEMBER 13, 2020
A new survey shows one in five cancer patients are far less likely to participate in future clinical trials due to fear of COVID-19 exposure, raising the question of whether enrollment levels that have dropped precipitously since the beginning of the pandemic are likely to recover after the virus is controlled. In an attempt to answer that question, researchers at the American Cancer Society (ACS) conducted the survey in response to a report from the SWOG Cancer Research Network that showed the
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
240 
Let's personalize your content